## BACKGROUND. A variable biochemical failure rate has been reported for patients undergoing radical prostatectomy. The authors analyzed their 1987-1993 prostatectomy experience retrospectively to stratify the risk of failure in order to appropriately select patients who potentially may benefit fr
Prediction of sexual function after radical prostatectomy
β Scribed by Alberto Briganti; Umberto Capitanio; Felix K.-H. Chun; Pierre I. Karakiewicz; Andrea Salonia; Marco Bianchi; Andrea Cestari; Giorgio Guazzoni; Patrizio Rigatti; Francesco Montorsi
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 135 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Models are available to accurately predict biochemical disease recurrence (BCR) after radical prostatectomy (RP). Because not all patients experiencing BCR will progress to metastatic disease, it is appealing to determine postoperatively which patients are likely to mani
## Abstract ## BACKGROUND Men who undergo radical prostatectomy (RP) are at longβterm risk of biochemical recurrence (BCR). In this report, the authors have described a model capable of predicting BCR up to at least 15 years after RP that can adjust predictions according to the diseaseβfree interv
## Abstract ## BACKGROUND. Morphologic and clinical heterogeneity within tumor grades is well recognized in prostate cancer. The objective of the current study was to determine whether the combined percentage of Gleason patterns 4 and 5 in radical prostatectomy specimens is an independent predicto
## Abstract Elevated matrix metalloproteinaseβ7 (MMPβ7) tissue expression and serum concentration have been shown to be associated with cancer progression and metastasis. The aim of our study was to assess the prognostic value of preoperative circulating MMPβ7 levels in serum samples of patients wi
## Abstract ## BACKGROUND: The authors previously developed and validated the Cancer of the Prostate Risk Assessment (CAPRA) score to predict prostate cancer recurrence based on pretreatment clinical data. They aimed to develop a similar postsurgical score with improved accuracy via incorporation